Pharmaceuticals

News

PHARMACEUTICALS NEWS

US tariffs on imported branded and patented medicines: ‘No major disruptions’ say Himachal pharmaceuticals producing generics

September 27, 2025 9:31 am

However, distinction between generic and branded is not always straightforward

Tweaks in drug formulations to extend copyrights is a public health challenge

October 28, 2024 10:35 am

As seen in the ongoing controversy surrounding pertuzumab, despite legal safeguards, evergreening remains an issue in launching affordable biosimilars.

Mankind Pharma sets IPO price band at Rs 1,026-1,080 per share

April 19, 2023 1:50 pm

Mankind Pharma said it has fixed a price band of Rs 1,026-1,080 a share for its Rs 4,326-crore initial public offering (IPO).

cadila, gujarat government, indian express

Cadila Pharmaceuticals signs MoU, to invest Rs 1,000 crore in Gujarat

March 22, 2023 3:02 pm

As per the agreement, the company will set up an Active Pharmaceuticals Ingredients (APIs) plant at Dahej, Bharuch and Ankleshwar and a Formation of Tablet and Capsules plant at Dholka.

France's Sanofi to acquire US-based Provention Bio for $2.9 billion

March 13, 2023 2:35 pm

With the acquisition, the French pharmaceutical group intends to acquire full ownership of an innovative treatment for the delay of stage 3 type 1 diabetes affecting about 65,000 people every year, it said in a statement.

Union Budget 2023: Why are Centres of Excellence for R&D in pharmaceuticals significant?

February 02, 2023 5:03 pm

Industry experts decode the cascading impact of Budget announcement on skill development, innovation and indigenous development of medical devices

Martin Shkreli is barred from the drug industry

January 15, 2022 8:18 am

🔴 Martin Shkreli is serving a seven-year prison sentence for defrauding investors related to his work running two hedge funds and a different pharmaceutical company.

BDR Pharma launches generic cancer drug in India

September 14, 2021 7:30 pm

Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma said in a statement.

New research: Oral drug fenofibrate may cut SARS-CoV-2 infection by 70%

August 06, 2021 1:16 pm

The team noted that additional unpublished data also indicates that fenofibrate is equally effective against the newer variants of SARS-CoV-2 including the Alpha and Beta variants.

Explained: How an unproven Alzheimer’s drug got approved

July 22, 2021 8:21 am

In announcing its approval in June, the FDA acknowledged there was not sufficient evidence that the drug would help patients. Instead, it said it was greenlighting Aduhelm under a program called “accelerated approval.”